RNTX
Rein Therapeutics
RNTX
RNTX
23 hedge funds and large institutions have $1.15M invested in Rein Therapeutics in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
72% less capital invested
Capital invested by funds: $4.03M → $1.15M (-$2.88M)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$127K | |
| 2 | +$87.7K | |
| 3 | +$25K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$17K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$9K |
Top Sellers
| 1 | -$312K | |
| 2 | -$253K | |
| 3 | -$126K | |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$83K |
| 5 |
ECM
Element Capital Management
New York
|
-$38K |